3-(2-Chloropyrimidin-4-yl)-5-morpholinobenzonitrile → HCID 25221251, compound
Reaction equation
Cl[C:2]1[N:7]=[C:6]([C:8]2[CH:9]=[C:10]([CH:13]=[C:14]([N:16]3[CH2:21][CH2:20][O:19][CH2:18][CH2:17]3)[CH:15]=2)[C:11]#[N:12])[CH:5]=[CH:4][N:3]=1.[CH3:22][O:23][CH:24]1[CH2:29][CH2:28][N:27]([C:30]2[N:34]=[CH:33][N:32]([C:35]3[CH:41]=[CH:40][C:38]([NH2:39])=[CH:37][CH:36]=3)[N:31]=2)[CH2:26][CH2:25]1>>[CH3:22][O:23][CH:24]1[CH2:29][CH2:28][N:27]([C:30]2[N:34]=[CH:33][N:32]([C:35]3[CH:41]=[CH:40][C:38]([NH:39][C:2]4[N:7]=[C:6]([C:8]5[CH:9]=[C:10]([CH:13]=[C:14]([N:16]6[CH2:21][CH2:20][O:19][CH2:18][CH2:17]6)[CH:15]=5)[C:11]#[N:12])[CH:5]=[CH:4][N:3]=4)=[CH:37][CH:36]=3)[N:31]=2)[CH2:26][CH2:25]1Participants
3
Procedure
3-(2-(4-(3-(4-methoxypiperidin-1-yl)-1H-1,2,4-triazol-1-yl)phenylamino)pyrimidin-4-yl-5-morpholinobenzonitrile was obtained by following procedure E using 3-(2-chloropyrimidin-4-yl)-5-morpholinobenzonitrile and 4-(3-(4-methoxypiperidin-1-yl)-1H-1,2,4-triazol-1-yl)aniline. MS (ESI) 538.23 (M+H).
Sources & evidence
- ORD record
- ord-4a8f3747ba384b56bd3d1fa2b50cbd7a
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09018205B2
Reaction notes
Loading…